TY - JOUR
T1 - Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene
AU - Chou, Sunwen
N1 - Funding Information:
Gail Marousek, Ronald J. Ercolani and Michelle A. Hendrick provided technical support. The work was supported by NIH grant AI116635 and Department of Veterans Affairs research funds.
Publisher Copyright:
© 2016 Elsevier B.V.
PY - 2017/2/1
Y1 - 2017/2/1
N2 - Human cytomegalovirus UL54 DNA polymerase gene mutations that confer foscarnet resistance in clinical practice typically cluster in the amino terminal 2, palm and finger domains. Exposure to foscarnet in cell culture selected for mutations elsewhere in UL54, including amino acid substitutions S290R in the amino terminal 1 domain and E951D in the palm 2 domain. These are newly confirmed to confer foscarnet resistance and slightly decreased ganciclovir susceptibility. Other emergent substitutions N495K, T552N and T838A are known to confer foscarnet resistance, while additional ones Q783R and V798A only slightly affected susceptibility. An expanded set of domains is involved in foscarnet resistance and its genotypic diagnosis.
AB - Human cytomegalovirus UL54 DNA polymerase gene mutations that confer foscarnet resistance in clinical practice typically cluster in the amino terminal 2, palm and finger domains. Exposure to foscarnet in cell culture selected for mutations elsewhere in UL54, including amino acid substitutions S290R in the amino terminal 1 domain and E951D in the palm 2 domain. These are newly confirmed to confer foscarnet resistance and slightly decreased ganciclovir susceptibility. Other emergent substitutions N495K, T552N and T838A are known to confer foscarnet resistance, while additional ones Q783R and V798A only slightly affected susceptibility. An expanded set of domains is involved in foscarnet resistance and its genotypic diagnosis.
UR - http://www.scopus.com/inward/record.url?scp=85003806642&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85003806642&partnerID=8YFLogxK
U2 - 10.1016/j.antiviral.2016.12.003
DO - 10.1016/j.antiviral.2016.12.003
M3 - Article
C2 - 27940027
AN - SCOPUS:85003806642
SN - 0166-3542
VL - 138
SP - 57
EP - 60
JO - Antiviral Research
JF - Antiviral Research
ER -